Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2008
10/02/2008US20080241923 Using cc-chemokine receptor 2 (CCR2) specific immunoglobulin for treatment and prevention of viral infection, inflammatory, autoimmune, graft rejection and cardivascular disorders
10/02/2008US20080241918 Hemagglutinin polypeptides, and reagents and methods relating thereto
10/02/2008US20080241884 Fused Protein Composition
10/02/2008US20080241882 Nucleotide sequences coding cell growth factor for use in diagnosis, prevention and treatment of nervous system disorders
10/02/2008US20080241863 Using DNA primer associated with hepatocellular carcinoma as evaluative tool in detecting hepatic disorders
10/02/2008US20080241862 Propionylation, butyrylation; detecting antibody binding; matrix-assisted laser desorption time-of-flight
10/02/2008US20080241861 Biological materials and methods useful in the diagnosis and treatment of diseases
10/02/2008US20080241859 Using aglycoprotein 10B antibody as diagnostic tool in detection of cell proliferative disorders associated with chronic viral diseases
10/02/2008US20080241857 Netrin receptors
10/02/2008US20080241855 GAG protein immunoglobulin fusion for use in detection of hepatitis C virus and human immunodeficiency viral infection
10/02/2008US20080241851 Cartilage intermediate layer protein 2 C1 and its use to differentiate osteoarthritis from rheumatoid arthritis and non-disease conditions
10/02/2008US20080241835 Differentially expressed genes involved in angiogenesis, the polypeptides encoded thereby, and methods of using the same
10/02/2008US20080241259 Method for production of bioresorbable microparticles, microparticles thus obtained and use thereof
10/02/2008US20080241207 Culture medium; antibodies; bioassays; drug screening; administering with an agonist or antagonist; stromal cells; implants
10/02/2008US20080241194 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage
10/02/2008US20080241191 Process and materials for the rapid detection of streptococcus pneumoniae employing purified antigen-specific antibodies
10/02/2008US20080241186 Nucleic acid vaccines for prevention of flavivirus infection
10/02/2008US20080241181 Streptococcal antigenic protein for use in generation of vaccines to prevent microorganismal infection
10/02/2008US20080241177 Idiotypic vaccine
10/02/2008US20080241175 Nucleotide sequences coding B7 immune response regulatory protein selectively expressed on dendritic cells for use as therapeutic tool in targeting viral and tumor cell for destruction
10/02/2008US20080241170 Increasing effectiveness of antigen cells expressing dendritic cell inhibitory receptor (DCIR); tissue targeted therapy
10/02/2008US20080241169 Using phage displayed prion specific immunoglobulin to prevent aggregation of amyloid plaques; treating alzheimer's disease
10/02/2008US20080241168 Transmembrane protein amigo and uses thereof
10/02/2008US20080241166 Ligands that bind a receptor
10/02/2008US20080241164 BMP-3 antibodies and related methods
10/02/2008US20080241163 Tweak binding antibodies
10/02/2008US20080241162 Hepatitis c viral E2 glycoprotein specific immunoglobulin for use in prevention and treatment of hepatitis infection
10/02/2008US20080241161 Liposome encapsulated antitumor immunoglobulin fusion for use in treatment of breast cell proliferative disorders
10/02/2008US20080241160 Interleukin-4 specific immunoglobulin for use in treatment and prevention of atopic, respiratory and allergic disorders
10/02/2008US20080241159 Methods and compositions for selective modulation of vascularization
10/02/2008US20080241158 G-protein coupled receptors for use in identifying modulators for treatment and prevention of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, metabolic and viral disorders
10/02/2008US20080241157 Nerve cell growth modulators (amphibodies)
10/02/2008US20080241156 Inhibitors of hepatitis C virus
10/02/2008US20080241154 Isolation, Identification and Characterization of tmst2, a Novel Member of the TNF-Receptor Supergene Family
10/02/2008US20080241153 Vascular Endothelial Growth Factor C (VEGF-C) Protein and Gene, Mutants Thereof, and Uses Thereof
10/02/2008US20080241152 Vascular Endothelial Growth Factor C (VEGF-C) Protein and Gene, Mutants Thereof, and Uses Thereof
10/02/2008US20080241151 Neisserial peptides for use in developing vaccine for prevention and treatment of menigococcal septicemia and meningitis
10/02/2008US20080241150 Peptide comprising Lin12-Notch repeats (LNR) for use in identifying and designing modulators for prevention and treatment of cell proliferative disorders
10/02/2008US20080241149 Antibodies to complementary peptides of thrombin or portions thereof
10/02/2008US20080241148 Treatment with anti-vegf antibodies
10/02/2008US20080241147 Using pleckstrin homology (PH) domain-interacting protein as tool in detection and identification of modulators for prevention and treatment of cell proliferative disorders
10/02/2008US20080241146 Apo-2 ligand-anti-Her-2 antibody synergism
10/02/2008US20080241145 Methods and compositions for immunotherapy and detection of inflammatory and immune-dysregulatory disease, infectious disease, pathologic angiogenesis and cancer
10/02/2008US20080241144 Prohibitin as Target for Cancer Therapy
10/02/2008US20080241143 Using selectin therapeutic in treatment of inflammatory bowel and joint disorders
10/02/2008US20080241142 Neuropilin/VEGF-C/VEGFR-3 Materials and Methods
10/02/2008US20080241138 Soluble il-17ra/rc fusion proteins and related methods
10/02/2008US20080241137 Cancerous disease modifying antibodies
10/02/2008US20080241136 Using cc-chemokine receptor 2 (CCR2) specific immunoglobulins for use in treatment and prevention of skin disorders
10/02/2008US20080241134 Uses of human monoclonal antibodies against oxidized ldl receptor
10/02/2008US20080241133 Novel 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 molecules and uses therefor
10/02/2008US20080241128 Antibodies; anticancer agents; autoimmune disorders
10/02/2008US20080241126 Nucleic acids encoding Human Engineered heavy and light chain variable region sequences to Ep-CAM
10/02/2008US20080241108 Bone Morphogenic Protein Binding Peptide
10/02/2008US20080241104 Espfu nucleic acids and proteins and uses thereof
10/02/2008US20080241103 Recombinant Virus Comprising an Intact Tumor-Therapeutic Antibody With Human Constant Regions and the Use Thereof
10/02/2008US20080241098 Antagonizing interleukin-21 receptor activity
10/02/2008US20080241096 IL-1 family variants
10/02/2008US20080241075 Parasite Vaccine
10/02/2008US20080241066 Anti-PRL-3 antibodies and methods of use thereof
10/02/2008US20080241062 Cancerous disease modifying antibodies
10/02/2008DE10101430B4 Lösliche cyclische Analoga zur Modulation der Amyloidogenese Soluble cyclic analogues in the modulation of amyloidogenesis
10/02/2008CA2719522A1 A non-destructive method to quantify and isolate antigen-specific b cells and uses thereof
10/02/2008CA2717659A1 Therapeutic applications of activation of human antigen-presenting cells through dectin-1
10/02/2008CA2682503A1 Cartilage intermediate layer protein 2 c1 and its use to differentiate osteoarthritis from rheumatoid arthritis and non-disease conditions
10/02/2008CA2682059A1 Human anti cd166 antibody binding human tumor cells
10/02/2008CA2682027A1 Modulation of tumor microenvironment
10/02/2008CA2681921A1 Peptides with anitfungal activity
10/02/2008CA2681792A1 Predictive renal safety biomarkers and biomarker signatures to monitor kidney function
10/02/2008CA2681530A1 Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereof
10/02/2008CA2681144A1 Cancer disease modifying antibody 010207-01 produced by hybridoma cell line ar51a630.3.
10/02/2008CA2680237A1 Constructs and libraries comprising antibody surrogate light chain sequences
10/02/2008CA2679332A1 Polypeptide recognized by anti hiv-1 gp41 antibodies isolated from highly hiv-1 exposed, non infected women
10/02/2008CA2653967A1 Lyase enzymes, nucleic acids encoding them and methods for making and using them
10/01/2008EP1975244A1 Method for measuring cholesterol in remnant-like lipoprotein
10/01/2008EP1975184A2 Serine or threonine phosphorylation sites
10/01/2008EP1975183A1 Tumour-specific recognition molecules
10/01/2008EP1975182A1 CD40-binding APC-activating molecules
10/01/2008EP1975181A1 Use of vascular endothelial cell growth factor antagonists
10/01/2008EP1975180A1 Treatment of autoimmune diseases with antibody anti gamma interferon
10/01/2008EP1975179A1 Polyclonal antibodies, preparation method thereof and use of same
10/01/2008EP1975178A1 Transcytotic modular antibody
10/01/2008EP1975175A2 IgA nephropathy-related DNA
10/01/2008EP1974749A1 Cripto blocking antibodies and uses thereof
10/01/2008EP1974748A2 Antibodies for the diagnosis of diseases associated with fibrosis
10/01/2008EP1974747A1 Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody
10/01/2008EP1974723A2 Secure forms of anti-EGFR antibodies
10/01/2008EP1974213A2 High sensitivity secretagogin assays and their uses for diagnosis and/or prognosis
10/01/2008EP1974048A1 Method for preparing antibodies selective for activating fc receptors
10/01/2008EP1974040A2 Compositions and methods for humanization and optimization of n-glycans in plants
10/01/2008EP1974020A1 Methods for obtaining immortalized antibody secreting cells
10/01/2008EP1973951A2 Binding polypeptides with restricted diversity sequences
10/01/2008EP1973950A2 Anti-ephb4 antibodies and methods using same
10/01/2008EP1973949A2 Anti-ox40l antibodies and methods using same
10/01/2008EP1973948A2 Methods and compositions for targeting polyubiquitin
10/01/2008EP1973947A2 Immunoconjugates with improved efficacy for the treatment of diseases
10/01/2008EP1973943A1 New method for the treatment of gout or pseudogout
10/01/2008EP1973940A2 Compositions and methods for humanization and optimization of n-glycans in plants
10/01/2008EP1973933A1 A NOVEL SURFACE EXPOSED HAEMOPHILUS INFLUENZAE PROTEIN (PROTEIN E; pE)
10/01/2008EP1973931A2 Chicken virus vaccine and diagnostic
1 ... 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 ... 1494